Skip to main content
. 2015 Jan 14;21(2):408–422. doi: 10.3748/wjg.v21.i2.408

Table 1.

Studies on acute hepatitis C treatment in hemodialysis patients

Ref. Süleymanlar et al[26] (1998) Gürsoy et al[27] (2001) Urbánek et al[28] (2004) Al-Harbi et al[29] (2005) Rocha et al[30](2007) Engel et al[32](2007) Liu et al[33](2010) Ferreira et al[31] (2011)
n 3 36 18 9 23 10 35 26
Interferon type IFN IFN IFN IFN IFN PEG-IFN α2b PEG-IFN α2a IFN
PEG-IFN α2a
Schedule 4.5 MU tiw 3 MU or 10 MU + 3 MU tiw 3 MU or 1 μg/kg qw 135 μgv qw 3 MU tiw
6-10 MU tiw 3 MU tiw 6 MU tiw or 135 μg qw
Duration 16 wk 12 wk 3 wk + 12 wk 12 wk 48 or 24 wk 24 wk 24 wk 48 wk
SVR 100% 39% 72% 67% 43% 40% 89% 54%

IFN: Interferon; PEG-IFN: Pegylated interferon; MU: Million units; tiw: Three times a week; qw: Once a week; SVR: Sustained virological response rate by intention-to-treat analysis.